Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric M Horwitz

Showing results (81-90 of 192) with videos related to

Pageof 20
Sort By:
American Journal of Clinical Oncology|June 21, 2016
The Missing Pieces in Reporting of Randomized Controlled Trials of External Beam Radiation Therapy Dose Escalation for Prostate CancerNicholas G Zaorsky, Brian L Egleston, Eric M Horwitz, et al.
The Prostate|January 31, 2007
Vitamin E succinate inhibits NF-kappaB and prevents the development of a metastatic phenotype in prostate cancer cells: implications for chemopreventionPaul L Crispen, Robert G Uzzo, Konstantin Golovine, et al.
Urology|September 19, 2015
Contemporary Trends in the Utilization of Radiotherapy in Patients With Renal Cell CarcinomaTalha Shaikh, Elizabeth A Handorf, Colin T Murphy, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 6, 2011
Young age under 60 years is not a contraindication to treatment with definitive dose escalated radiotherapy for prostate cancerTracy L Klayton, Karen Ruth, Eric M Horwitz, et al.
International Journal of Radiation Oncology, Biology, Physics|February 15, 2012
Prostate bed motion during intensity-modulated radiotherapy treatmentTracy Klayton, Robert Price, Mark K Buyyounouski, et al.
Research and Reports in Urology|August 31, 2016
A comparison of robotic arm versus gantry linear accelerator stereotactic body radiation therapy for prostate cancerVladimir Avkshtol, Yanqun Dong, Shelly B Hayes, et al.
Cancer|June 22, 2011
Long-term survival after radical prostatectomy versus external-beam radiotherapy for patients with high-risk prostate cancerStephen A Boorjian, R Jeffrey Karnes, Rosalia Viterbo, et al.
International Journal of Radiation Oncology, Biology, Physics|January 22, 2008
A comparison of acute and chronic toxicity for men with low-risk prostate cancer treated with intensity-modulated radiation therapy or (125)I permanent implantThomas N Eade, Eric M Horwitz, Karen Ruth, et al.
International Journal of Radiation Oncology, Biology, Physics|July 19, 2011
Radiotherapy doses of 80 Gy and higher are associated with lower mortality in men with Gleason score 8 to 10 prostate cancerNiraj Pahlajani, Karen J Ruth, Mark K Buyyounouski, et al.
International Journal of Radiation Oncology, Biology, Physics|January 24, 2007
The proportion of prostate biopsy tissue with Gleason pattern 4 or 5 predicts for biochemical and clinical outcome after radiotherapy for prostate cancerDavid J D'Ambrosio, Alexandra L Hanlon, Tahseen Al-Saleem, et al.
Pageof 20

Showing results (81-90 of 192) with videos related to

Sort By:
Pageof 20
American Journal of Clinical Oncology|June 21, 2016
The Missing Pieces in Reporting of Randomized Controlled Trials of External Beam Radiation Therapy Dose Escalation for Prostate CancerNicholas G Zaorsky, Brian L Egleston, Eric M Horwitz, et al.
The Prostate|January 31, 2007
Vitamin E succinate inhibits NF-kappaB and prevents the development of a metastatic phenotype in prostate cancer cells: implications for chemopreventionPaul L Crispen, Robert G Uzzo, Konstantin Golovine, et al.
Urology|September 19, 2015
Contemporary Trends in the Utilization of Radiotherapy in Patients With Renal Cell CarcinomaTalha Shaikh, Elizabeth A Handorf, Colin T Murphy, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 6, 2011
Young age under 60 years is not a contraindication to treatment with definitive dose escalated radiotherapy for prostate cancerTracy L Klayton, Karen Ruth, Eric M Horwitz, et al.
International Journal of Radiation Oncology, Biology, Physics|February 15, 2012
Prostate bed motion during intensity-modulated radiotherapy treatmentTracy Klayton, Robert Price, Mark K Buyyounouski, et al.
Research and Reports in Urology|August 31, 2016
A comparison of robotic arm versus gantry linear accelerator stereotactic body radiation therapy for prostate cancerVladimir Avkshtol, Yanqun Dong, Shelly B Hayes, et al.
Cancer|June 22, 2011
Long-term survival after radical prostatectomy versus external-beam radiotherapy for patients with high-risk prostate cancerStephen A Boorjian, R Jeffrey Karnes, Rosalia Viterbo, et al.
International Journal of Radiation Oncology, Biology, Physics|January 22, 2008
A comparison of acute and chronic toxicity for men with low-risk prostate cancer treated with intensity-modulated radiation therapy or (125)I permanent implantThomas N Eade, Eric M Horwitz, Karen Ruth, et al.
International Journal of Radiation Oncology, Biology, Physics|July 19, 2011
Radiotherapy doses of 80 Gy and higher are associated with lower mortality in men with Gleason score 8 to 10 prostate cancerNiraj Pahlajani, Karen J Ruth, Mark K Buyyounouski, et al.
International Journal of Radiation Oncology, Biology, Physics|January 24, 2007
The proportion of prostate biopsy tissue with Gleason pattern 4 or 5 predicts for biochemical and clinical outcome after radiotherapy for prostate cancerDavid J D'Ambrosio, Alexandra L Hanlon, Tahseen Al-Saleem, et al.
Pageof 20